Furiex Pharmaceuticals, Inc. (FURX) Misses Q1 EPS by 62c

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) reported Q1 EPS of ($1.25), $0.62 worse than the analyst estimate of ($0.63). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $10.01 million.

For earnings history and earnings-related data on Furiex Pharmaceuticals, Inc. (FURX) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance
• Pan American Silver (PAAS) Misses Q2 EPS by 19c